Felix Ramos-Guerrero
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Sasanlimab taken together with Bacillus Calmette-Guérin (BCG) compared with BCG alone in people with high-risk non-muscle invasive bladder cancer: a plain language summary.
Journal: Future oncology (London, England)
Published: May 24, 2026
Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.
Journal: Urologic oncology
Published: April 20, 2026
Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.
Journal: World journal of urology
Published: April 12, 2026
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study.
Journal: BJU international
Published: April 06, 2026
Current perspectives and controversies in urothelial carcinoma: from treatment expansion to decision complexity.
Journal: Current opinion in urology
Published: March 31, 2026
The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial.
Journal: The oncologist
Published: March 20, 2026
Latest developments in urinary tumor DNA and its current clinical role in urothelial bladder cancer and upper tract urothelial carcinoma.
Journal: Current opinion in urology
Published: March 13, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.
Journal: BJU international
Published: March 03, 2026
Recommendations for the prevention and treatment of adverse effects of intravesical BCG.
Journal: Actas urologicas espanolas
Published: March 02, 2026
Pragmatic Clinical End points for High-risk NMIBC: A Path to Accelerated Market Access in Europe.
Journal: European urology oncology
Published: February 26, 2026
Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.
Journal: Actas urologicas espanolas
Published: February 02, 2026
Improving Long-Term Monitoring in NMIBC: Digital Uromonitor® (dUM) as a Complementary Tool to Cystoscopy for Two-Year Recurrence Risk Stratification.
Journal: Actas urologicas espanolas
Published: February 02, 2026
Last Updated: 09/26/2026